|
BHLHB9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62536650805123E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
8.38090000000458E-05 |
| Normal-vs-Stage3 |
1.584480E-03 |
| Normal-vs-Stage4 |
2.92000001955728E-09 |
| Stage1-vs-Stage2 |
2.757000E-01 |
| Stage1-vs-Stage3 |
8.050400E-02 |
| Stage1-vs-Stage4 |
3.873800E-01 |
| Stage2-vs-Stage3 |
4.926400E-01 |
| Stage2-vs-Stage4 |
2.240800E-01 |
| Stage3-vs-Stage4 |
1.156950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62470037423645E-12 |
| Normal-vs-AfricanAmerican |
1.15399911848613E-11 |
| Normal-vs-Asian |
2.824600E-01 |
| Caucasian-vs-AfricanAmerican |
6.715800E-01 |
| Caucasian-vs-Asian |
8.638100E-02 |
| AfricanAmerican-vs-Asian |
1.690450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
3.39250000003233E-06 |
| Male-vs-Female |
2.649800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.95089500110157E-11 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
8.00880473050825E-11 |
| Normal-vs-Extreme_Obese |
1.56989999888779E-08 |
| Normal_Weight-vs-Extreme_Weight |
5.280200E-01 |
| Normal_Weight-vs-Obese |
3.252800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.079800E-01 |
| Extreme_Weight-vs-Obese |
5.384000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.476600E-01 |
| Obese-vs-Extreme_Obese |
5.005800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.18529999999451E-05 |
| Normal-vs-Age(41-60Yrs) |
5.72852876246088E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.177040E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.052400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.712600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.023200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.047700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.039000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.305800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
3.02089464554456E-11 |
| Normal-VS-KIRP CIMP |
5.40567590689989E-12 |
| Normal-VS-Unclassified PRCC |
7.004500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.276300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.163820E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.693640E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.809200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.773150E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.575100E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.46399567416233E-11 |
| Normal-vs-N1 |
2.382800E-03 |
| Normal-vs-N2 |
4.97600000004539E-06 |
| N0-vs-N1 |
2.437400E-01 |
| N0-vs-N2 |
4.488000E-01 |
| N1-vs-N2 |
3.267800E-01 |
|
|
